Clinical Research Directory
Browse clinical research sites, groups, and studies.
A Randomised-controlled Trial of an Oral Microbiome Immunity Formula in Recovered COVID-19 Patients
Sponsor: Chinese University of Hong Kong
Summary
This study aims to evaluate the effectiveness of an oral microbiome immunity formula in modulating gut microbiota, enhancing immunity and reducing long-term complications and co-morbidities in patients who have recovered from COVID-19.
Official title: A Randomised-controlled Trial of an Oral Microbiome Immunity Formula in Reducing Development of Long-term Co-morbidities in Recovered COVID-19 Patients
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
448
Start Date
2021-06-25
Completion Date
2027-12-31
Last Updated
2024-08-22
Healthy Volunteers
No
Interventions
Microbiome immunity formula
Microbiome immunity formula contains probiotics blend (3Bifidobacteria, 20 billion CFU daily)
Active placebo
Active placebo contains active vitamin
Locations (1)
Prince of Wales Hospital
Hong Kong, Hong Kong